Insulin Resistance  >>  Invokana (canagliflozin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Invokana (canagliflozin) / J&J, Daiichi Sankyo, Mitsubishi Tanabe
NCT02220920: Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

Completed
4
146
Japan
Canagliflozin (TA-7284), Placebo, Insulin
Mitsubishi Tanabe Pharma Corporation
Type 2 Diabetes Mellitus
07/15
07/15
NCT02227849: Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus

Completed
4
71
Japan
Canagliflozin (TA-7284), GLP-1 analogue
Mitsubishi Tanabe Pharma Corporation
Type 2 Diabetes Mellitus
03/16
03/16

Download Options